Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment.
AUTOR(ES)
Bluestone, R
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1010524Documentos Relacionados
- Treatment of scleroderma heart by D-penicillamine.
- Myelotoxicity of D-penicillamine.
- Cholestatic jaundice caused by D-penicillamine.
- Thrombokinetics in patients with rheumatoid arthritis treated with D-penicillamine.
- Progressive proliferative glomerulonephritis in a patient with rheumatoid arthritis treated with D-penicillamine.